- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03476005
Proficiency Based Training to Investigate WBIT
Technology Enhanced Learning and Proficiency Based Progression to Investigate and Mitigate 'Wrong Blood in Tube' in Our Hospitals; Can we Improve Patient Safety and Reduce Resource Wastage?
Incorrect labelling of blood samples occurs at a rate of 1% in the general laboratories and 6% in Blood Transfusion Laboratories. The most serious error 'Wrong Blood in Tube' (WBIT) occurs when blood is taken from the intended patient, but labelled with another patient's details. Consequences may include, misinterpretation of a patient's diagnosis or clinical status, incorrect referral or treatment of a patient, or in the worst case scenario, incorrect cross matching for blood of the wrong blood group, which may lead to catastrophic outcomes, including death.
The root causes for these errors is failure to identify the patient correctly and failure to correctly label the blood tubes at the bedside. To date, despite significant initiatives, it has proved very difficult to eradicate or reduce the error rate. Our project involves a novel, technology enhanced learning approach using proficiency based progression in a prospective randomised controlled methodology to significantly reduce this error.
This approach to learning is more efficient and effective than the traditional approach of repeated practice and is made possible with metric-based simulations. This project will reduce the incidence of adverse events and avoidable medical errors associated with sampling and labelling errors including WBITs. This will be achieved by training healthcare practitioners to a proficiency standard in venepuncture. Thereby minimising the failure of health care professionals to identify the patient correctly and failure to correctly label the blood tubes at the bedside.
This project's impact will deliver reduced sampling and labelling errors -including WBITs by a factor of 40-69%. Reductions of this magnitude will have profound national and international implications on how these types of skills are acquired and quality assured. This would result in improved patient safety and savings of over €500,000 at Cork University Hospital and if applied nationally result in exchequer savings of millions of euro annually.
Study Overview
Status
Intervention / Treatment
Detailed Description
The goal of the study is identification, development and operational definition and then validation of phlebotomy performance Metrics which will be used to characterize the optimal performance of healthcare practitioner's execution of phlebotomy. These validated Metrics will serve as an educational and training tool to improve and quality assure phlebotomy training. The validated metrics will be used to produce validated metric-based simulations which will be used to establish a training benchmark based on experienced clinicians' performance. It will also be used to underpin deliberate practice in simulated training.
By introducing proficiency-based progression training supported by technology enhanced learning we aim for reductions in the error rates of wrong blood in tube of 40 to 69%.
Objective 1 To characterize the process of taking a blood sample correctly and the correct process for labelling a blood sample bottle and laboratory request form to reduce the incidence of wrong blood in tube.
This will involve metric development and metric validation of the process of taking a blood sample correctly and the correct process for labelling a blood sample bottle and laboratory request form - as a result of a consultative process, including qualitative analysis of WBIT errors.
Objective 2 To quantitatively define a proficiency benchmark and then to design training to the proficiency standard and assessment of proficiency up to and including real time feedback to the doctor and patient in the clinical arena.
Objective 3 Design a new approach to training including assessment using technology enhanced learning, incorporating online learning and simulation based training of taking a blood sample to a proficiency standard.
Objective 4 To implement the training and assessment in the highest risk groups and document the effectiveness of the intervention.
The training will be delivered to all interns commencing work at Cork University Hospital on July 10th 2017 as proficiency based progression simulation training with additional systematic proximate feedback.
Data from each training group will be identified using the laboratory tracking quality system and using comparison with the historical data from the previous year(s).
Objective 5 To use the research data generated to recommend an evidence based training and competency assessment approach to health care providers in Ireland, together with evidence based individual feedback for any residual errors. This will allow us to internationally address the universal problem of sample mislabeling and WBIT.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cork, Ireland
- CUH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
All historical interns blood samples from July to Sept 2016 All interns who receive training and working at Cork University Hospital from July to Sept 2017
Exclusion Criteria:
Interns in 2017 who do not attend for training
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Proficiently Trained interns -
Provided with proficiency based progression training supported by technology enhanced learning
|
proficiency based progression training supported by technology enhanced learning
|
No Intervention: Historical controls
no extra training provided
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
WBIT
Time Frame: 3 months
|
Wrong blood in tube
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
wrong bottle type
Time Frame: 3 months
|
incorrect bottle type used
|
3 months
|
under filled samples
Time Frame: 3 months
|
number of under filled samples which did not allow analysis
|
3 months
|
clotted samples
Time Frame: 3 months
|
Number of clotted samples
|
3 months
|
haemolysed samples
Time Frame: 3 months
|
number of haemolysed haematology samples
|
3 months
|
Mislabelling
Time Frame: 3 months
|
Mislabelling of forms/bottles in blood bank
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Mary Cahill, MD, UCC
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- #1710
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transfusion Related Complication
-
Institutul Clinic FundeniCompletedTransfusion Related ComplicationRomania
-
Centre Hospitalier Universitaire de BesanconUnknownTransfusion Related Complication
-
RenJi HospitalNot yet recruitingTransfusion Related Complication
-
Leyla KılıncCompletedTransfusion Related ComplicationTurkey
-
University Hospital, CaenUnknownTransfusion Related ComplicationFrance
-
Centre Hospitalier Universitaire de BesanconTerminatedPostoperative; Dysfunction Following Cardiac Surgery | Transfusion Related ComplicationFrance
-
Samsung Medical CenterUnknownBleeding | Transfusion Related ComplicationKorea, Republic of
-
James ReynoldsNational Heart, Lung, and Blood Institute (NHLBI); Case Western Reserve UniversityRecruitingTransfusion Related ComplicationUnited States
-
The Mediterranean Institute for Transplantation...Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Medical University... and other collaboratorsCompletedHemorrhage | Extracorporeal Membrane Oxygenation Complication | Anticoagulant-induced Bleeding | Transfusion Related ComplicationItaly
-
Second Affiliated Hospital, School of Medicine,...CompletedSpinal Fusion | Pulmonary Complication | TransfusionChina
Clinical Trials on proficiency based progression training
-
Jorio MascheroniCompletedKnowledge, Attitudes, PracticeBelgium
-
Patrick HennCork University HospitalCompletedWrong Blood in Tube | Blood Transfusion Complication | Pre Analytical Blood Sample ErrorsIreland
-
Dorothy BreenUniversity of Ulster; Health Research Board, Ireland; Cork University Hospital; Health Service Executive, Ireland and other collaboratorsRecruitingAdverse EventsIreland
-
Arthroscopy Association of North AmericaCompletedStudy Focus: Simulation and Proficiency Based TrainingUnited States
-
University College CorkCompletedPerformance | Simulation | Clinical Communication | ISBAR | Proficiency-Based Progression | Non Technical Skills | Deteriorating PatientIreland
-
Royal College of Surgeons, IrelandHealth Service ExecutiveUnknownColorectal DiseaseUnited Kingdom, Ireland
-
Cork University HospitalCompleted
-
Rigshospitalet, DenmarkCompleted
-
VA Office of Research and DevelopmentTerminatedOsteoarthritisUnited States